MenaQ7

The Optimal Vitamin K2
Benifit Image
Clinically Studied
Clinically-studied Vitamin K2 for Bone and Cardiovascular Health
Benifit Image
Pure
First pure natural Vitamin K2 Crystals, > 95% MK-7
Benifit Image
Patented
First patented Vitamin K2 for Heart Health

What is MenaQ7?

MenaQ7 is a natural source of Vitamin K2 in the form of menaquinone-7 (MK-7). It is a fermentation extract of Bacillus
licheniformis, providing soy-free vitamin K2 production. MK-7 is recognized in the scientific literature for providing an important source of vitamin K.

 

Good For
Ingredient Solutions
Bone, Joint & Muscle
Cardiovascular
Applications
Capsules
Powders
Tablets
Mena Q7 Main Image

Why MenaQ7?

Research demonstrates the importance of vitamin K2 in helping the body utilize calcium to build strong, healthy bones and to inhibit calcium deposits in the arteries.

MenaQ7 Crystals

MenaQ7 Crystals, the purest natural MK-7 available, represents the most significant evolution of a vitamin with significant health benefits. An important technological breakthrough in the new generation of MenaQ7 is a proprietary multi-step process of purification, condensation and crystallization of fermentation-derived vitamin K2. This innovative process leads to an end product that is more than 95% pure natural MK-7.

Heart Health
home-respiratory
Research
CLINICALLY-STUDIED VITAMIN K2 FOR BONE AND CARDIOVASCULAR HEALTH

The average dietary intake of Kvitamins has dropped significantly over the last 50 years, and today’s intake is believed to be insufficient. Research shows that vitamin K2 is beneficial for both bone and cardiovascular health. MenaQ7 is the best-documented natural vitamin K2 (MK-7) menaquinone product.

ViTAMiN K2 (MK-7) REsEARCH

The First Breakthrough study:

“The Rotterdam study” (1) The beneficial effects of vitamin K2 have been well documented through years of research. The large-scale 10-year Rotterdam study (2004)showed improved cardiovascular health in individuals consuming higher vs. lower levels of vitamin K2.

The Second Breakthrough study:

“The MenaQ7 study” (2) Results of a new double-blind, randomized clinical trial showed that when taken daily in nutritional doses (180 mcg) for three years, MenaQ7 improved bone mineral density, bone strength and cardiovascular health. Because of its long-term design, this study was the first MK-7 trial to show these benefits. This was also the first study to show clear,statistically significant improvements in bone health and cardiovascular health.


(1) Geleijnse JM et al. (2004) dietary intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study.Journal of Nutrition 134: s3100-3105
(2) Knapen MHJ et al. (2013) Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International Sep; 24 (9): 2499-507
(3) Knapen MHJ et al (2015) Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: double-blind randomized clinical trial. Thromb Haemost 113: epub ahead of print

MENAQ7 is a registered trademark of NattoPharma ASA.

Resources
Related Offsite Articles
NattoPharma MenaQ7: The Vitamin K2 Expert
DANIELLE LIN: THE SCIENCE OF LIFE -SEPTEMBER, 2017
Go to Video
New Review Identifies Roles of Vitamins K2 and D for Children’s Bone Health
NATURAL PRODUCTS INSIDER - SEPTEMBER, 2017
Go to article
Shining a Light on Vitamin K
NATURAL PRODUCTS INSIDER - AUGUST, 2017
Go to article

Ready to realize your product’s full potential?

We work closely with our customers and our world-wide suppliers to source and scientifically back innovative ingredients for your product development needs.